Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Pain Resilience and Pain Self-Efficacy as Parallel Mediators of the Relationship Between Self-Critical Rumination and Pain-Specific Well-Being in Individuals With Chronic Pain: A Structural Equation Modeling Study

22 de septiembre de 2026 actualizado por: Semanur Bilgiç, Bilecik Seyh Edebali Universitesi

This study is a cross-sectional, correlational, and analytical study designed to examine the parallel mediating roles of pain resilience and pain self-efficacy in the relationship between self-critical rumination and pain-specific well-being in individuals with chronic pain. Structural equation modeling will be used to simultaneously evaluate the direct and indirect relationships between the variables.

Descripción general del estudio

Estado

Aún no reclutando

Condiciones

Descripción detallada

Chronic pain is a multidimensional health issue that affects not only an individual's physical functioning but also their psychological adjustment and well-being. It is posited that negative cognitive patterns-such as self-critical rumination-can adversely affect an individual's pain experience and well-being, whereas psychological resources-such as pain resilience and pain self-efficacy-may play a significant role in mitigating these effects. This study was designed to examine the parallel mediating roles of pain resilience and pain self-efficacy in the relationship between self-critical rumination and pain-specific well-being in individuals with chronic pain.

Tipo de estudio

De observación

Inscripción (Estimado)

451

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Estudio Contacto

Ubicaciones de estudio

    • Bilecik
      • Bilecik, Bilecik, Turquía (Türkiye), 11000
        • Bilecik Seyh Edebali University
        • Contacto:

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

No

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Having chronic pain that has persisted or recurred for at least three months

Descripción

Inclusion Criteria:

  • Individuals aged 18 years and older,
  • Having chronic pain that has persisted or recurred for at least three months,
  • Being followed up for chronic pain at the Physical Therapy and Rehabilitation Outpatient Clinic,
  • Able to read and understand Turkish and communicate at a level sufficient to complete data collection forms,
  • And agreeing to participate in the research voluntarily will be included.

Exclusion Criteria:

  • Individuals with pain lasting less than three months or experiencing only acute pain,
  • Individuals with cancer-related pain,
  • Individuals in the palliative or terminal stage,
  • Individuals who have undergone major surgery within the last three months and still experience acute/postoperative pain related to the surgery,
  • Individuals with cognitive or communication impairments that would prevent them from understanding the research questions and independently responding to the data collection instruments will be excluded.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

  • Modelos observacionales: OTHER
  • Perspectivas temporales: CROSS_SECTIONAL

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Numerical Rating Scales
Periodo de tiempo: 1 days

Numerical Rating Scales (NRS): In alignment with the IASP Classification of Chronic Pain for the International Classification of Diseases (ICD-11), participants' pain intensity over the past week, the impact of pain on daily activities, and the level of pain-related distress will be assessed separately using 0-10 numerical rating scales. Pain intensity will be rated from 0 ("no pain") to 10 ("worst pain imaginable"); the impact of pain on daily life from 0 ("no impact") to 10 ("completely prevents my activities"); and pain-related distress from 0 ("no distress") to 10 ("extreme distress").

1 days
The University of Washington Pain-Related Self-Efficacy Scale-Short Form
Periodo de tiempo: 1 days

The University of Washington Pain-Related Self-Efficacy Scale-Short Form is a 6-item scale developed to assess patients' perceptions regarding their self-efficacy-or confidence-in performing daily, social, and personal activities despite pain. Each item is rated on a 5-point Likert-type scale ranging from 1 ("not at all confident") to 5 ("completely confident"). Total scores on the scale range from 6 to 30, with higher scores indicating a higher level of pain-related self-efficacy. The Cronbach's alpha value was reported as 0.87 in the study regarding the Turkish validity and reliability of the scale.

1 days
Well-Being in Pain Questionnaire
Periodo de tiempo: 1 days

This scale was developed to assess well-being in the presence of pain among individuals with chronic pain, as well as the psychological, social, and lifestyle-related characteristics that support such well-being. The scale consists of a total of 11 items rated on a 5-point Likert scale ranging from 0 ("never") to 4 ("almost always"). The total score is calculated by summing the responses to all items and ranges from 0 to 44. Higher scores indicate a higher level of pain-related well-being; a score of 0 represents the minimum level, while a score of 44 represents the maximum level of pain-related well-being. In the study regarding the Turkish validity and reliability of the scale, the Cronbach's alpha value was reported as 0.713.

1 days
Self-Critical Rumination Scale
Periodo de tiempo: 1 days

Self-Critical Rumination Scale: Developed by Smart et al. (2016) to assess ruminative processes associated with self-critical thoughts, this scale consists of 10 items. Respondents rate how well the statements describe them using a 4-point Likert-type scale (1 = does not describe at all, 2 = describes very little, 3 = describes moderately, 4 = describes very well). In the original study examining its psychometric properties, the scale's internal consistency coefficient was found to be .92, and it was determined to have a single-factor structure. It was also reported that the scale shows high correlations with constructs related to both self-criticism and rumination. In the study regarding the Turkish validity and reliability of the scale, the Cronbach's alpha value was reported as 0.89.

1 days
Pain Resilience Scale
Periodo de tiempo: 1 days

Pain Resilience Scale: This is a 14-item scale that assesses the cognitive, emotional, and behavioral responses individuals exhibit when facing intense or prolonged pain. The scale comprises two sub-dimensions: behavioral persistence (items 1-5) and a positive cognitive-emotional approach (items 6-14). Items are scored on a scale ranging from 0 ("never") to 4 ("always"). In the Turkish version of the PRS, only items 8, 11, and 12 are reverse-scored; for these items, the scoring is reversed from 4 ("always") to 0 ("never"). A high total score on the scale indicates a high level of pain resilience. The Cronbach's alpha value was reported as 0.920 in the study establishing the scale's validity and reliability in Turkish.

1 days

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Patrocinador

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Estimado)

31 de octubre de 2026

Finalización primaria (Estimado)

30 de junio de 2027

Finalización del estudio (Estimado)

1 de diciembre de 2027

Fechas de registro del estudio

Enviado por primera vez

16 de septiembre de 2026

Primero enviado que cumplió con los criterios de control de calidad

22 de septiembre de 2026

Publicado por primera vez (Actual)

29 de septiembre de 2026

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

29 de septiembre de 2026

Última actualización enviada que cumplió con los criterios de control de calidad

22 de septiembre de 2026

Última verificación

1 de septiembre de 2026

Más información

Términos relacionados con este estudio

Otros números de identificación del estudio

  • kronik ağrı-2

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .